AQR Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $538K | Buy |
|
|||||
|
2025
Q1 | $181K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $758K | Sell |
|
|||||
|
2024
Q2 | $2.72M | Buy |
|
|||||
|
2024
Q1 | $2.52M | Buy |
|
|||||
|
2023
Q4 | $2.13M | Buy |
|
|||||
|
2023
Q3 | $1.37M | Buy |
|
|||||
|
2023
Q2 | $833K | Buy |
|
|||||
|
2023
Q1 | $914K | Sell |
|
|||||
|
2022
Q4 | $942K | Buy |
|
|||||
|
2022
Q3 | $580K | Buy |
|
|||||
|
2022
Q2 | $328K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.9M | Sell |
|
|||||
|
2020
Q2 | $4.44M | Sell |
|
|||||
|
2020
Q1 | $3.51M | Buy |
|
|||||
|
2019
Q4 | $4.67M | Buy |
|
|||||
|
2019
Q3 | $1.94M | Buy |
|
|||||
|
2019
Q2 | $244K | Sell |
|
|||||
|
2019
Q1 | $480K | Buy |
|
|||||
|
2018
Q4 | $508K | Buy |
|
|||||
|
2018
Q3 | $629K | Sell |
|
|||||
|
2018
Q2 | $932K | Sell |
|
|||||
|
2018
Q1 | $2.16M | Buy |
|
|||||
|
2017
Q4 | $2.31M | Sell |
|
|||||
|
2017
Q3 | $2.74M | Sell |
|
|||||
|
2017
Q2 | $2.6M | Sell |
|
|||||
|
2017
Q1 | $2.71M | Sell |
|
|||||
|
2016
Q4 | $5.57M | Sell |
|
|||||
|
2016
Q3 | $7.1M | Buy |
|
|||||
|
2016
Q2 | $5.61M | Buy |
|
|||||
|
2016
Q1 | $2.5M | Sell |
|
|||||
|
2015
Q4 | $3.94M | Sell |
|
|||||
|
2015
Q3 | $3.84M | Sell |
|
|||||
|
2015
Q2 | $6.09M | Sell |
|
|||||
|
2015
Q1 | $8.31M | Sell |
|
|||||
|
2014
Q4 | $9.13M | Buy |
|
|||||
|
2014
Q3 | $5.92M | Buy |
|
|||||
|
2014
Q2 | $2.11M | Buy |
|
|||||
|
2014
Q1 | $1.72M | Buy |
|
|||||
|
2013
Q4 | $356K | Buy |
|